Vertex Wins FDA Approval for Expanded Cystic Fibrosis Treatment
Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) shares saw a handy gain on Thursday after the U.S. Food and Drug Administration (FDA) gave the...
Orkambi Not Seen to Significantly Improve Blood Glucose Levels in CF Patients in Small Study
Analysis of blood glucose levels in cystic fibrosis (CF) patients being treated with Orkambi (ivacaftor/lumacaftor) shows that the...
Acebilustat Seen to Prevent Pulmonary Exacerbations in CF Patients in Phase 2b Trial
Topline data from a Phase 2b trial showed that the investigative therapy acebilustat taken once daily can reduce the number and frequency...
Specific Gene Mutation Causes Severe CF in Georgian Jewish Patients, Study Reports
The Q359K/T360K gene mutation, which is commonly found in Jewish patients of Georgian descent, is associated with a particularly severe...
CF Babies More Likely to be Born Preterm, Weigh Less, Study Finds
Babies with cystic fibrosis (CF) are more likely to be born preterm — less than 37 weeks of pregnancy — and have significantly lower...
Supplemental antioxidants may reduce exacerbations in cystic fibrosis
An antioxidant-enriched vitamin may decrease respiratory exacerbations in people with cystic fibrosis (CF), according to new research...